The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Molina Healthcare Inc

NYSE: MOH
Last

(U.S.) $55.89

Today's change+1.34 +2.46%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.
 

Molina Healthcare Inc

NYSE: MOH
Last

(U.S.) $55.89

Today's change+1.34 +2.46%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

Molina Healthcare Inc up sharply

Molina Healthcare Inc closed up sharply Friday, rallying (U.S.)$1.34 or 2.46% to (U.S.)$55.89. Over the last five days, shares have gained 6.95%, but are down 7.05% for the last year to date. Shares have outperformed the S&P 500 by 4.80% during the last year.

Key company metrics

  • Open(U.S.) $54.98
  • Previous close(U.S.) $54.55
  • High(U.S.) $56.68
  • Low(U.S.) $54.17
  • Bid / Ask-- / --
  • YTD % change-7.05%
  • Volume1,343,330
  • Average volume (10-day)1,214,910
  • Average volume (1-month)979,997
  • Average volume (3-month)1,001,268
  • 52-week range(U.S.) $48.00 to (U.S.) $82.37
  • Beta1.73
  • Trailing P/E21.26×
  • P/E 1 year forward15.16×
  • Forward PEG0.70×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.63
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1.02%

Based on its net profit margin of 1.02%, Molina Healthcare Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Healthcare Facilities

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue3,7653,6113,5253,171
Total other revenue--------
Total revenue3,7653,6113,5253,171
Gross profit565561563499
Total cost of revenue3,2003,0502,9622,672
Total operating expense3,6893,4993,4093,089
Selling / general / administrative461423422392
Research & development--------
Depreciation / amortization28262525
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income7611311682
Interest income (expense), net non-operating-22-15-15-15
Gain (loss) on sale of assets--------
Other--------
Income before tax569810167
Income after tax30463928
Income tax, total26516239
Net income30463928
Total adjustments to net income--------
Net income before extra. items30463928
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items30463928
Inc. avail. to common incl. extra. items30463928
Diluted net income30463928
Dilution adjustment--------
Diluted weighted average shares58605050
Diluted EPS excluding extraordinary itemsvalue per share0.520.770.770.56
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.520.770.770.56